Predictors, moderators and mediators for the effectiveness of pexelizumab treatment in patients undergoing primary coronary revascularization.
Gen-Min
GM
Lin
Yi-Hwei
YH
Li
Shu-Hui
SH
Wen
Shu-Yuan
SY
Chen
Kai-Min
KM
Chu
Chih-Lu
CL
Han
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D003324:Coronary Artery Disease / Q000097:blood / Q000628:therapy*; D016903:Drug Monitoring / Q000379:methods*; D006801:Humans; D008954:Models, Biological; D009204:Myocardial Revascularization / Q000379:methods*; D010974:Platelet Aggregation / Q000187:drug effects*; D011237:Predictive Value of Tests; D057127:Single-Chain Antibodies / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D057127:Single-Chain Antibodies; C402724:pexelizumab